Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

People who’ve been using more affordable copycat versions of Ozempic or Wegovy to lose weight will ... In February, the U.S. Food and Drug Administration declared the shortage to be over.

Ozempic and Wegovy have a boxed warning for risk of thyroid cancer. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). To learn more, see the “Precautions ...

Low-sugar, high-protein yoghurt Oikos has benefited from Danone's GLP-1 focus - Oikos. One in eight U.S. adults has now tried ...

GLP-1 drugs include Ozempic and Rybelsus, both of which have been approved by the Food and Drug Administration to treat diabetes. They also include Saxenda and Wegovy, which the FDA approved for ...

Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy took a hit due to rising competition from off-brand, or compounded, versions of the treatment, according to the Danish pharma ...

Ultra-slim beauty norms may be re-emerging, and some analysts predict changes to our collective appetite for junk food. In the era of Wegovy, we could also see an increase in the stigma around ...

If you want to stop using Wegovy, it is important to continue any other lifestyle changes you’ve made to support weight loss, such as eating a low calorie diet and increasing your physical activity.

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...